Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
At a glance
This grant offers funding for “Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes”. The notice gives 16 September 2027 as the deadline.
Key facts
Each fact is from the official notice, last checked 14 November 2026, 05:51 (UTC+01:00).
- Status
- OpenOfficial notice · checked 14 Nov 2026, 05:51 (UTC+01:00)
- Deadline
- (in 306 days)Official notice · checked 14 Nov 2026, 05:51 (UTC+01:00)
The call
As the source publishes it. The official call is authoritative; Inteliwert does not assess eligibility.
- Programme
- Horizon Europe (HORIZON) (43108390)
- Call
- Supporting the implementation of the Cancer Mission (HORIZON-MISS-2027-02)
- Topic
- HORIZON-MISS-2027-02-CANCER-03
- Type of action
- HORIZON-RIA HORIZON Research and Innovation Actions
- Submission
- Forthcoming
- Deadline model
- single-stage
- Opens
- 10 February 2027
- Deadlines
- 16 September 2027
- Budget as published
- €24,000,000 (budget years 2027)
- Expected grants
- 3
- Contribution per grant
- €7,000,000 to €9,000,000
- Applicant types
- The source publishes no applicant types as data; the official call says who may apply.
Eligibility, in the source’s words
2. Eligible countries
described in Annex B of the Work Programme General Annexes. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other Eligibility Conditions
described in Annex B of the Work Programme General Annexes.
Official call · checked 14 Nov 2026, 05:51 (UTC+01:00)
© European Union, CC BY 4.0. Inteliwert shows the call’s facts in its own layout; the official call is authoritative.
Timeline
- 14 November 2026, 05:51 (UTC+01:00): Original notice Notice, version 6e6f92c61c377160. Official notice
Official documents
No documents found in the indexed notice.
Questions and answers
When is the application deadline?
The official notice gives 16 September 2027 as the deadline.
How do I apply?
On the official notice or the portal it names. Inteliwert does not submit applications. Official notice
Am I eligible?
Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice
Source
- Publisher
- European Commission
- Licence
- CC BY 4.0
- Official notice
- https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-MISS-2027-02-CANCER-03
- Last checked
- 14 November 2026, 05:51 (UTC+01:00)
The official notice is authoritative. Inteliwert shows what the notice states and links to it.